Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07339748 | A Clinical Study of ZL-85FA Tablets | not yet recruiting | Phase 1 / Phase 2 | 51 | Chengdu Zenitar Biomedical Technology Co., LtdINDUSTRY | 1 | Jan 15, 2026 | clinicaltrials |
| NCT07342738 | TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors | not yet recruiting | Early Phase 1 | 25 | Sun Yat-sen UniversityOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT07333664 |
| Image-Guided 125I Seed Implantation Plus Standard Systemic Therapy for Patients With Multiple Metastatic Lesions |
| not yet recruiting |
| Phase 2 |
| 120 |
| Li MinOTHER |
| 1 |
| Jan 12, 2026 |
| clinicaltrials |
| NCT07327294 | A Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid Tumor | not yet recruiting | Phase 1 / Phase 2 | 150 | Evopoint Biosciences Inc.INDUSTRY | 1 | Jan 8, 2026 | clinicaltrials |
| NCT07327411 | Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors | not yet recruiting | Phase 2 | 40 | Second Affiliated Hospital of Soochow UniversityOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT07307053 | Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2) | not yet recruiting | Phase 1 / Phase 2 | 600 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 0 | Dec 29, 2025 | clinicaltrials |
| NCT05522491 | Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer | not yet recruiting | Phase 2 | 30 | Hebei Medical University Fourth HospitalOTHER | 0 | Dec 11, 2025 | clinicaltrials |
| NCT07275853 | Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors | not yet recruiting | Phase 1 | 30 | TCRx Therapeutics Co.LtdINDUSTRY | 1 | Dec 10, 2025 | clinicaltrials |
| NCT07272590 | Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 290 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 0 | Dec 9, 2025 | clinicaltrials |
| NCT07267234 | PRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0) | not yet recruiting | Phase 2 | 65 | Second Affiliated Hospital of Soochow UniversityOTHER | 0 | Dec 5, 2025 | clinicaltrials |
| NCT07260058 | Immune Cell Therapy for Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 48 | Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.INDUSTRY | 0 | Dec 2, 2025 | clinicaltrials |
| NCT07252661 | Study of ACC-1898 in Adult Participants With Advanced Solid Tumors | not yet recruiting | Phase 1 | 40 | AccSalus Biosciences, Inc.INDUSTRY | 0 | Nov 28, 2025 | clinicaltrials |
| NCT07249892 | A Study of BPR-6023021 in Advanced Solid Tumors With Bone Metastases | not yet recruiting | Phase 1 / Phase 2 | 195 | Chengdu Syncor Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 25, 2025 | clinicaltrials |
| NCT07245901 | Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 60 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Nov 24, 2025 | clinicaltrials |
| NCT07178938 | Platform Trial Assessing Uptake, Safety and Efficacy of Theranostic Agents in Solid Tumors With Active Brain Metastases(THERANOVA) | not yet recruiting | Phase 2 | 10 | MedSIROTHER | 0 | Nov 14, 2025 | clinicaltrials |
| NCT07224568 | Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors(INTERCEPT) | not yet recruiting | Phase 1 | 21 | Seattle Children's HospitalOTHER | 1 | Nov 4, 2025 | clinicaltrials |
| NCT07207681 | Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors | not yet recruiting | Phase 1 | 30 | The First Hospital of Jilin UniversityOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT06933524 | Evaluation of Safety and Tolerability of ATB-320 in Participants With Progressive or Metastatic Solid Tumors(ATB-320-001A) | not yet recruiting | Phase 1 | 24 | AutotelicbioINDUSTRY | 0 | Oct 1, 2025 | clinicaltrials |
| NCT07196579 | Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors | not yet recruiting | Phase 1 | 30 | TCRx Therapeutics Co.LtdINDUSTRY | 1 | Sep 29, 2025 | clinicaltrials |
| NCT06798532 | Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors(AKA-NBL) | not yet recruiting | — | 150 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT07170787 | A Study of IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 104 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc.OTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT07157956 | CVL006 Combination Therapy in Advanced Solid Tumors(CVL006-T1002) | not yet recruiting | Phase 1 / Phase 2 | 318 | Convalife (Shanghai) Co., Ltd.INDUSTRY | 1 | Sep 5, 2025 | clinicaltrials |
| NCT07128576 | Romiplostim N01 for the Treatment of Thrombocytopenia Associated With Radiotherapy-Combined Treatment Regimens in Patients With Solid Tumors | not yet recruiting | Phase 2 | 60 | Zhujiang HospitalOTHER | 0 | Sep 4, 2025 | clinicaltrials |
| NCT07142837 | Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 153 | Suzhou Zelgen Biopharmaceuticals Co.,LtdINDUSTRY | 1 | Aug 27, 2025 | clinicaltrials |
| NCT07136558 | Evaluation of ICP-B794 in Patients With Advanced Solid Tumors | not yet recruiting | Phase 1 | 410 | Beijing InnoCare Pharma Tech Co., Ltd.INDUSTRY | 1 | Aug 22, 2025 | clinicaltrials |
| NCT07124195 | Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting | not yet recruiting | Phase 3 | 126 | The First Affiliated Hospital of Xinxiang Medical CollegeOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT05888857 | MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors.(TAYLOR) | not yet recruiting | Phase 2 | 102 | Institut BergoniéOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT07110363 | A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer | not yet recruiting | Phase 1 | 58 | Biotroy TherapeuticsINDUSTRY | 0 | Aug 7, 2025 | clinicaltrials |
| NCT07107178 | A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma | not yet recruiting | Phase 1 | 58 | Biotroy TherapeuticsINDUSTRY | 0 | Aug 6, 2025 | clinicaltrials |
| NCT07101549 | Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18) | not yet recruiting | Phase 1 | 25 | changjianhuaOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT07088588 | Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors | not yet recruiting | Phase 1 | 105 | Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdINDUSTRY | 1 | Jul 28, 2025 | clinicaltrials |
| NCT07077252 | Phase I/II Study of SCTB39G in Advanced Solid Tumours | not yet recruiting | Phase 1 / Phase 2 | 30 | Sinocelltech Ltd.INDUSTRY | 1 | Jul 22, 2025 | clinicaltrials |
| NCT07061639 | A Study of QLS5133 Monotherapy in Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 212 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 11, 2025 | clinicaltrials |
| NCT07057349 | CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer | not yet recruiting | Phase 1 | 40 | Cytosite Biopharma Inc.INDUSTRY | 1 | Jul 9, 2025 | clinicaltrials |
| NCT07051161 | Impact of Interventional Endoscopy on Quality of Life in Patients With Acute Respiratory Distress Due to Tumor Compression or Obstruction of the Lower Respiratory Tract(ENDoRA) | not yet recruiting | — | 60 | University Hospital, GrenobleOTHER | 0 | Jul 4, 2025 | clinicaltrials |
| NCT07049458 | Study of CHO-A04 in Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 62 | Cho Pharma Inc.INDUSTRY | 1 | Jul 3, 2025 | clinicaltrials |
| NCT07030478 | A Study to Evaluate the Safety and Tolerability of EP0089 | not yet recruiting | Phase 1 / Phase 2 | 190 | Ellipses PharmaINDUSTRY | 0 | Jun 22, 2025 | clinicaltrials |
| NCT07002502 | Immune Modulation With PRaG-1 Treatment | not yet recruiting | Phase 2 | 19 | Second Affiliated Hospital of Soochow UniversityOTHER | 0 | Jun 10, 2025 | clinicaltrials |
| NCT06998173 | Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DAT-1604 in Advanced Solid Tumor | not yet recruiting | Phase 1 | 228 | Danatlas Pharmaceuticals Co., LtdINDUSTRY | 1 | May 31, 2025 | clinicaltrials |
| NCT06999538 | Real-life Performance Evaluation of the LiFlow X-ray Platform(LiFE) | not yet recruiting | — | 400 | University Hospital, AngersOTHER_GOV | 0 | May 31, 2025 | clinicaltrials |
| NCT06991478 | SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites | not yet recruiting | Phase 1 / Phase 2 | 10 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | May 28, 2025 | clinicaltrials |
| NCT06976931 | Study on the Safe Dosage and Therapeutic Effect of the Drug YY2201 Tablets on Patients With Advanced Cancer | not yet recruiting | Early Phase 1 | 42 | Jiangsu YaYao Biotechnology Co., Ltd.INDUSTRY | 0 | May 16, 2025 | clinicaltrials |
| NCT06970132 | Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation | not yet recruiting | Phase 1 / Phase 2 | 102 | Shouyao Holdings (Beijing) Co. LTDOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT06951425 | An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors | not yet recruiting | Early Phase 1 | 24 | Shanghai Tongji Hospital, Tongji University School of MedicineOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06966583 | NAD+ Supplement(NMN)With Radioimmunotherapy in Advanced NSCLC(NMN) | not yet recruiting | Phase 1 | 20 | Sichuan UniversityOTHER | 1 | May 12, 2025 | clinicaltrials |
| NCT06963398 | A Study of HS-10529 in KRAS G12D Patients With Advanced Solid Tumors | not yet recruiting | Phase 1 | 520 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 0 | May 9, 2025 | clinicaltrials |
| NCT06963502 | A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors | not yet recruiting | Phase 1 | 762 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 9, 2025 | clinicaltrials |
| NCT06956261 | NW-301 TCR-T in Patients With Advanced Solid Tumor | not yet recruiting | Phase 1 | 44 | Peking UniversityOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT06955390 | Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 32 | Henan Cancer HospitalOTHER_GOV | 1 | May 2, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jan 15, 2026source: clinicaltrials